BioSpace News Archive

Anticipated to be Israel’s first pure-play cannabis firm to go public on a Canadian stock exchange; focused on becoming the world’s leading low-cost, high-grade producer

“Finish Strong” Tells How to Take Charge of Your End-of-Life Care and Avoid Needless Suffering

According to Coherent Market Insights, the global central venous catheter market is valued at US$ 1,167.4 million in 2017, and is projected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026)

Believes stock is worth at least four times current trading levels

Continuous flow manufacture is an innovative technology platform which is gaining momentum within the pharmaceutical industry with the FDA supporting the adoption for the manufacture of APIs.

The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018.

UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, today announced topline results from the ongoing pivotal Phase 3 OLYMPUS clinical trial of UGN-101 (mitomycin gel) for instillation, an investigational mitomycin formulation for the non-surgical treatment of low-grade upper tract urothelial cancer (UTUC)

BulletinHealthcare announced that it has launched its latest briefing, Radiology Daily Briefing

Company filed patent application for the utilization of Namodenoson as an anti-obesity drug

Today SleepScore Labs, the company built by the sleep experts behind the world’s most accurate, non-contact sleep monitoring technology and curated store of sleep products, announced an Exclusive Strategic Relationship Agreement with SleepScore Ventures, the first and only venture program focused exclusively on product and company solutions committed to improving sleep.